Tag: AMERICAN THORACIC SOCIETY

lungs barbed wire
Pharmaceuticals & Therapuetics

Idiopathic Pulmonary Fibrosis Drugs Appear To Increase Longevity and Decrease Hospitalizations

Two drugs to reduce the scarring of the lungs that occurs in patients with idiopathic pulmonary fibrosis (IPF) appear to increase longevity and decrease hospitalizations, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Clinical Effectiveness of the Anti-Fibrotic Medications […]

Research & Innovation

ATS Report Finds Urgent Problems with Supplemental Oxygen Services

A new report published in the December Annals of the American Thoracic Society (AnnalsATS) highlights the problems many patients with lung disease experience in getting and using supplemental oxygen.  In “Optimizing Home Oxygen Therapy: An Official American Thoracic Society Workshop Report,” 26 physicians, nurses, respiratory therapists, patients and representatives of the Centers for […]

Patient Care

New Guideline Aids in Diagnosing Idiopathic Pulmonary Fibrosis

A new international guideline has been developed to help physicians diagnosis idiopathic pulmonary fibrosis (IPF), a rare and often fatal lung disease whose cause is unknown. The 2018 clinical practice guideline was developed by experts representing four major respiratory societies—the American Thoracic Society (ATS), the European Respiratory Society (ERS), Japanese […]

Respiratory

Tobacco Regulation Advocates Get Support from Medical Professional Organizations in Court Filing

The American Thoracic Society led 10 medical professional organizations in filing an amicus brief last week regarding the FDA’s failure to apply pre-market review to new tobacco products. The brief was submitted in support of the American Academy of Pediatrics and its co-plaintiffs and outlines the compelling data indicating that the FDA’s failure to act […]